STAT

Pharma contributions to politicians who support restricting abortions could reverberate

Source: DOMINICK REUTER/AFP/Getty Images

If you’re a drug maker, you wouldn’t contribute to political candidates whose positions might crimp your bottom line, right?

Well, you might.

Drug makers, of course, regularly contribute to both Republican and Democratic candidates. But in some cases, a candidate’s view could have negative repercussions for the very products these companies market. And this appears to be possible when it comes to the highly charged issue of abortion, which is once again becoming a major flashpoint in the nation’s political discourse.

Take the case of Pfizer (), Merck (), and Johnson & Johnson (). Each company sells contraceptive products. Pfizer markets Depo-Provera, Merck sells Nexplanon,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks